https://www.selleckchem.com/products/eg-011.html
Activated macrophages may also contribute to the development of anemia by shortening the erythrocyte lifespan. Proper management of the underlining conditions is necessary in treating anemia associated with inflammation. Erythropoiesis-stimulating agents may be administered to patients with chronic kidney disease, whereas anti-IL-6 agents may be beneficial for anemic patients with rheumatoid arthritis and idiopathic multicentric Castleman disease.Acquired pure red cell aplasia (PRCA) is characterized by normocytic anemia, reticulocytopen
Like
Comment
Share
